1. Skin Barrier Dysregulation in Psoriasis
   Andreas Orsmond et al, 2021, International Journal of Molecular Sciences CrossRef
2. Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα
   Julia Tittes et al, 2024, Dermatology and Therapy CrossRef
3. Acitretin Promotes the Differentiation of Myeloid-Derived Suppressor Cells in the Treatment of Psoriasis
   Panpan Liu et al, 2021, Frontiers in Medicine CrossRef
4. Peripheral expansion of myeloid-derived suppressor cells is related to disease activity and damage accrual in inflammatory myopathies
   Jiram Torres-Ruiz et al, 2023, Rheumatology CrossRef
5. Regulatory cells in the skin: Pathophysiologic role and potential targets for anti-inflammatory therapies
   Sagar Uttarkar et al, 2019, Journal of Allergy and Clinical Immunology CrossRef
6. Inducible nitric oxide synthase-expressing myeloid-derived suppressor cells regulated by interleukin 35 contribute to the pathogenesis of psoriasis
   Junfeng Zhang et al, 2023, Frontiers in Immunology CrossRef
7. Genome-wide DNA methylation and transcription analysis in psoriatic epidermis
   Lingxi Liu et al, 2023, Epigenomics CrossRef
8. Circulating CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells as Potential Biomarkers for the Identification of Psoriasis TCM Blood-Heat Syndrome and Blood-Stasis Syndrome
   Shipeng Sun et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
9. Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2)
   David C. Soler et al, 2022, Molecular Immunology CrossRef
10. Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
    Francesca Maria Consonni et al, 2019, Frontiers in Immunology CrossRef
11. Differential Phenotypes of Myeloid-Derived Suppressor and T Regulatory Cells and Cytokine Levels in Amnestic Mild Cognitive Impairment Subjects Compared to Mild Alzheimer Diseased Patients
    Aurélie Le Page et al, 2017, Frontiers in Immunology CrossRef
12. Ze-Qi-Tang formula inhibits MDSCs glycolysis through the down-regulation of p21/Hif1α/Glut1 signal in psoriatic-like mice
    Yangzhuangzhuang Zhu et al, 2024, Phytomedicine CrossRef
13. Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation
    Luca Cassetta et al, 2020, Journal for ImmunoTherapy of Cancer CrossRef
14. In vitro differentiation of myeloid suppressor cells (MDSC-like) from an immature myelomonocytic precursor THP-1
    Vanessa Araújo Varela et al, 2023, Journal of Immunological Methods CrossRef
15. Interleukin-17E, inducible nitric oxide synthase and arginase1 as new biomarkers in the identification of neutrophilic dermatoses
    R. Stalder et al, 2022, Clinical and Experimental Dermatology CrossRef
16. Targeting Myeloid-Derived Suppressor Cells Is a Novel Strategy for Anti-Psoriasis Therapy
    Chao Chen et al, 2020, Mediators of Inflammation CrossRef
17. Targeting upregulation of the immunosuppressive activity of MDSCs with indirubin as a novel strategy to alleviate psoriasis
    Yifei Hou et al, 2023, International Immunopharmacology CrossRef
18. Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms
    Anna Grohová et al, 2020, PLOS ONE CrossRef
19. Emerging role of immune cell network in autoimmune skin disorders: An update on pemphigus, vitiligo and psoriasis
    Dayasagar Das et al, 2019, Cytokine & Growth Factor Reviews CrossRef
20. Matrix metalloproteinase-7 could be a predictor for acute inflammation in psoriatic patients
    Arbia Abbes et al, 2020, Cytokine CrossRef